| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6116425 | Diagnostic Microbiology and Infectious Disease | 2011 | 4 Pages |
Abstract
Polymyxin B (PB) plus meropenem (MER) or rifampin (RIF) was tested by Etest® method and time-kill assay (TKA) against 14 genetically unique clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. PB + MER: Etest, 43% synergy; TKA, 64% synergy. Concordance between methods was 79%. For PB + RIF: Etest, 21% synergy; TKA, 100% synergy. Concordance between methods was 21%.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
George A. Pankey, Deborah S. Ashcraft,